Role of high-affinity receptors and membrane transporters in nonsynaptic communication and drug action in the central nervous system

Pharmacological Reviews

Volumn 52, Issue 1, 2000, Pages 63-89

  Vizi, E Sylvester ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4 AMINOBUTYRIC ACID RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; ADENOSINE A1 RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; CARRIER PROTEIN; CHOLINESTERASE INHIBITOR; DOPAMINE RECEPTOR; DOPAMINE TRANSPORTER; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMATE TRANSPORTER; MUSCARINIC RECEPTOR; NEUROLEPTIC AGENT; NICOTINIC RECEPTOR; PRESYNAPTIC RECEPTOR; PROTEIN KINASE C; PURINE P2X RECEPTOR; PURINE P2Y RECEPTOR; SEROTONIN 3 RECEPTOR; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

CELL MEMBRANE; EXTRACELLULAR SPACE; HUMAN; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; RECEPTOR DENSITY; REVIEW;

ANIMALS; CELL COMMUNICATION; CENTRAL NERVOUS SYSTEM; HUMANS; MEMBRANES; RECEPTORS, NEUROTRANSMITTER; SYNAPTIC TRANSMISSION;

EID: 0034005665     PISSN: 00316997     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (481)

1. 2+-independent release of neurotransmitters. J Neurochem 58:395-405.
2. 3H-noradrenaline secretion in guinea-pig vas deferens. J Physiol (Lond) 312:297-334.
3. A receptors on hippocampal neurons. J Pharmacol Exp Ther 279:1491-1506.
4. Alkondon M, Pereira EFR, Barbosa CTF and Albuquerque EX (1997) Neuronal nicotinic acetylcholine receptor activation modulates γ-aminobutyric acid release from CA1 neurons or rat hippocampal slices. J Pharmacol Exp Ther 283:1396-1411.
5. 2+ current in rat magnocellular cholinergic basal forebrain neurons. J Physiol (Lond) 466:173-189.
6. Allen TGJ and Brown DA (1996) Detection and modulation of acetylcholine release from neuntes of rat basal forebrain cells in culture. J Physiol (Lond) 492:453-466.
7. 2-adrenoceptors in brain slices. Naunyn-Schmiedeberg's Arch Pharmacol 345:402-409.
8. 3H]-noradrenaline release in rabbit hippocampus and human neocortex. Br J Pharmacol 116:1769-1774.
9. Amara SG and Kuhar MJ (1993) Neurotransmitter transporters: recent progress. Annu Rev Neurosci 16:73-93.
10. 2+ uptake in diazepam withdrawal: Inhibition by baclofen. Pharm Biochem Behav 41:695-699.
11. Apparsundaram S, Schroeter S, Giovanetti E and Blakely RD (1998) Acute regulation of norepinephrine transport: II. PKC-modulated surface expression of human norepinephrine transporter proteins. J Pharmacol Exp Ther 287:744-751.
12. Asztely F, Erdemli G and Kullmann DM (1997) Extrasynaptic glutamate spillover in the hippocampus: Dependence on temperature and the role of active glutamate uptake. Neuron 18:281-293.
13. Attwell D, Barbour B and Szatkowski M (1993) Nonvesicular release of neurotransmitter. Neuron 11:401-407.
14. Bach-y-Rita P (1993) Neurotransmission in the brain by diffusion through the extracellular fluid: A review. Neuroreport 4:343-350.
15. 3 receptor-mediated effect in the raphe nuclei of the rat. Brain Res Bull 45:203-208.
16. Baker PF and Crawford AC (1975) A note on the mechanism by which inhibitors of the sodium pump accelerate spontaneous release of transmitter from motor nerve terminals. J Physiol (Lond) 247:209-226.
17. 3H-serotonin release from hippocampal synaptosomes. Eur J Pharmacol 68:11-16.
18. Barbour B, Brew H and Attwell D (1988) Electrogenic glutamate uptake in glial cells is activated by intracellular potassium. Nature (Lond) 335:433-435.
19. Barbour B and Häusser M (1997) Intersynaptic diffusion of neurotransmitter. Trends Neurosci 20:377-384.
20. Barker EL and Blakely RD (1995) Norepinephrine and serotonin transporters: Molecular targets of antidepressant drugs, in Psychopharmacology: The Fourth Generation of Progress (Bloom FE and Kupfer DJ eds) pp 321-333, Raven Press, New York.
21. A receptors: Classification on the basis of subunit structure and receptor function. Pharmacol Rev 50:291-313.
22. 3H]-L-glutamate release from rat hippocampal synaptosomes. Br J Pharmacol 113:339-341.
23. Baude A, Nusser Z, Molnar E, McIlhinney RA and Somogyi P (1995) High-resolution immunogold localization of AMPA type glutamate receptor subunits at synaptic and nonsynaptic sites in rat hippocampus. Neuroscience 69:1031-1055.
24. Bean BP (1992) Pharmacology and electrophysiology of ATP-activated ion channels. Trends Pharmacol Sci 13:87-90.
25. Beaudet A and Descarries L (1978) The monoamine innervation of the cerebral cortex: synaptic and nonsynaptic action terminals. Neuroscience 3:851-860.
26. Beaudet A and Sotelo C (1981) Synaptic remodeling of serotonin axon terminals in rat agranular cerebellum. Brain Res 16:305-329.
27. Benveniste H and Hüttemeier PC (1990) Microdialysis: Theory and application. Prog Neurobiol 35:195-215.
28. Bernáth S (1992) Calcium independent release of amino acid neurotransmitters: Fact or artifact? Prog Neurobiol 38:57-91.
29. Besret L, Debruyne D, Rioux P, Bonvalot T, Moulin M, Zarifian E and Baron JC (1996) A comprehensive investigation of plasma and brain regional pharmacokinetics of imipramine and its metabolites during and after chronic administration in the rat. J Pharm Sci 85:291-295.
30. Bettler B and Mulle C (1995) Neurotransmitter receptors. II. AMPA and kainate receptors (Review). Neuropharmacology 34:123-139.
31. 2-Adrenergic agonists reduce glutamate release and glutamate receptor-mediated calcium changes in hippocampal slices during hypoxia. Neuropharmacology 35:679-687.
32. 4 receptors on inhibition in the guinea-pig dentate gyrus in vitro. Neuroscience 78:1017-1026.
33. 2-agonists in reserpinized and normal mice. Br J Pharmacol 96:144-152.
34. B receptor isoforms GBR1a and GBR1b, appear to be associated with pre-and post-synaptic elements respectively in rat and human cerebellum. Br J Pharmacol 128:1387-1392.
35. Blakeley AG and Cunnane TC (1979) The packeted release of transmitter from the sympathetic nerves of the guinea-pig vas deferens: an electrophysiological study. J Physiol (Lond) 296:85-96.
36. Blakeley RD, DeFelice LJ and Hartzell HC (1994) Molecular physiology of norepinephrine and serotonin transporters. J Exp Biol 196:263-281.
37. 2A-adrenoceptor subtype. Eur J Pharmacol 205:311-313.
38. 2 adrenoceptor subtypes. J Pharmacol Exp Ther 267:1054-1060.
39. Boehm S (1999) ATP stimulates sympathetic transmitter release via presynaptic P2X purinoceptors. J Neurosci 19:737-746.
40. 3H]mazindol. J Pharmacol Exp Ther 253:1206-1214.
41. B receptor pharmacology. Annu Rev Pharmacol Toxicol 33:109-147.
42. 3H]dopamine from synaptosomes. J Pharmacol Exp Ther 248:514-520.
43. Bönisch H (1986) The role of co-transported sodium in the effect of indirectly acting sympathomimetic amines. Naunyn-Schmiedeberg's Arch Pharmacol 332:135-141.
44. Bönisch H and Brüss M (1994) The noradrenaline transporter of the neuronal plasma membrane. Ann NY Acad Sci 733:193-202.
45. A receptors. J Physiol (Lond) 497:753-759.
46. Brooks-Kayal AR, Munir M, Jin H and Robinson MB (1998) The glutamate transporter, GLT-1, is expressed in cultured hippocampal neurons. Neurochem Int 33:95-100.
47. 2A purine receptors regulate striatal acetylcholine release. J Neurochem 55:31-38.
48. Brundige JM and Dunwiddie TV (1997) Role of adenosine as a modulator of synaptic activity in the central nervous system. Adv Pharmacol 39:353-391.
49. Budd SL (1998) Mechanisms of neuronal damage in brain hypoxia/ischemia: Focus on the role of mitochondrial calcium accumulation. Pharmacol Ther 80:203-229.
50. Buma P (1989) Characterization of luteinizing hormone-releasing hormone fibres in the mesencephalic central grey substance of the rat. Neuroendocrinology 49:623-630.
51. Bunin M and Wightman RM (1998) Quantitative evaluation of 5-hydroxytryptamine (serotonin) neuronal release and uptake: An investigation of extrasynaptic transmission. J Neurosci 18:4854-4860.
52. Bunin MA, Prioleau C, Mailman RB and Wightman RM (1998) Release and uptake of 5-hydroxytryptamine in the dorsal raphe and substantia nigra reticulata of the rat brain. J Neurochem 70:1072-1087.
53. Bunin MA and Wightman RM (1999) Paracrine neurotransmission in the CNS: involvement of 5-HT. Trends Neurosci 22:377-382.
54. Burger PM, Mehl E, Cameron PL, Maycox PR, Baumert M, Lottspeich F, De Camilli P and Jahn R (1989) Synaptic vesicles immunoisolated from rat cerebral cortex contain high levels of glutamate. Neuron 3:715-720.
55. Buzsáki G and Chrobak JJ (1995) Temporal structure in spatially organized neuronal ensembles: A role for interneuronal networks. Curr Opin Neurobiol 5:504-510.
56. 2 Adrenergic Receptors (Limbird L ed) pp 1-13, Humana Press, Clifton, NJ.
57. 2D adrenergic receptor subtypes, in Adrenoceptors: Structure, Mechanism, Function (Szabadi E and Bradshaw CM eds) pp 27-36, Birkhauser Verlag, Basel.
58. 2-adrenergic receptors: Comparison of pharmacologically defined subtypes with subtypes identified by molecular cloning. Mol Pharmacol 42:1-5.
59. Bylund DB, Eikenberg DC, Hieble JP, Langer SZ, Lefkowitz RJ, Minneman KP, Molinoff PB, Ruffolo RR Jr and Trendelenburg U (1994) IV International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol Rev 46:121-136.
60. 2B adrenergic receptor subtypes: Antagonist binding in tissues and cell lines containing only one subtype. J Pharmacol Exp Ther 245:600-607.
61. 3H]rauwolscine. J Neurochem 51:81-86.
62. 2A-adrenoceptor agonist binding sites in brains of depressed suicide victims. J Neurochem 70:1114-1123.
63. Caulfield MP (1993) Muscarinic receptors: Characterization, coupling and function. Pharmacol Ther 58:319-379.
64. Caulfield MP and Birdsall NJM (1998) International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev 50:279-290.
65. 3H]dopamine release from rat hippocampal slices through sigma-1 binding sites. Neurochem Int 33:29-34.
66. Charney DS, Menkes DB and Heninger GR (1981) Receptor sensitivity and the mechanism of action of antidepressant treatment. Arch Gen Psychiatry 38:1160-1180.
67. Chen N and Justice JB Jr (1998) Cocaine acts as an apparent competitive inhibitor at the outward-facing conformation of the human norepinephrine transporter: Kinetic analysis of inward and outward transport. J Neurosci 18:10257-10268.
68. Chiodini FC, Tassonyi E, Hulo S, Bertrand D and Muller D (1999) Modulation of synaptic transmission by nicotine and nicotinic antagonists in hippocampus. Brain Res Bull 48:623-628.
69. Chittajallu R, Vignes M, Dev KK, Barnes JM, Collingridge GL and Henley JM (1996) Regulation of glutamate release by presynaptic kainate receptors in the hippocampus. Nature (Lond) 379:78-81.
70. 3H]dopamine release. Br J Pharmacol 117: 595-606.
71. Clements JD (1996) Transmitter timecourse in the synaptic cleft: Its role in central synaptic function. Trends Neurosci 19:163-171.
72. Clements JD, Lester RA, Tong G, Jahr CE and Weatbrook GL (1992) The time course of glutamate in the synaptic cleft. Science (Wash DC) 258:1498-1501.
73. Colguhoun D and Odgen DC (1988) Activation of ion channels in the frog end-plate by high concentrations of acetylcholine. J Physiol (Lond) 395:131-159.
74. Conn RJ and Pin J-P (1997) Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol 37:205-237.
75. Corey JL, Davidson N, Lester HA, Brecha N and Quick MW (1994) Protein kinase C modulates the activity of cloned γ-aminobutyric acid transporter expressed in Xenopus oocytes via regulated subcellular redistribution of the transporter. J Biol Chem 269:14759-14767.
76. Corradetti R, Lo Conte G, Moroni F, Passani MB and Pepeu G (1984) Adenosine decreases aspartate and glutamate release from rat hippocampal slices. Eur J Pharmacol 104:19-26.
77. 3H]-noradrenaline from hippocampal slices. Br J Pharmacol 123:473-480.
78. 3H]γ-aminobutyric acid release by kainate receptor activation in rat hippocampal synaptosomes. Eur J Pharmacol 323:167-172.
79. 2A receptors stimulate acetylcholine release from nerve terminals of the rat hippocampus. Neurosci Lett 196:41-44.
80. 3H]acetylcholine release from different areas of the rat hippocampus. J Neurochem 63:207-214.
81. + in rat striatal slices. Neurochem Int 33:35-40.
82. Dale HH (1935) Pharmacology and nerve endings. Proc R Soc Med Ther Sect 28: 319-332.
83. Daszuta A, Chazal G, Garcia S, Oleskevich S and Descarries L (1991) Ultrastructural features of serotonin neurons grafted to adult rat hippocampus: An immunocytochemical analysis of their cell bodies and axon terminals. Neuroscience 42:793-811.
84. 2-adrenoceptor sensitivity with chronic treatment: Assessment with clonidine inhibition of acoustic startle. Br J Pharmacol 77:217-222.
85. Davis GW and Murphey RK (1994) Retrograde signaling and the development of transmitter release properties in the invertebrate nervous system. J Neurobiol 25:740-756.
86. Dawson TD and Snyder SH (1994) Gases as biological messengers: Nitric oxide and carbon monoxide in the brain. J Neurosci 14:5147-5159.
87. 2-adrenoceptors in depressed suicides. Brain Res 757:60-68.
88. De Potter WP and Chubb IW (1971) The turnover rate of noradrenergic vesicles. Biochem J 125:375-376.
89. De Potter WP, Chubb IW, Put A and De Schaepdryver AF (1971) Facilitation of the release of noradrenaline and dopamine-β-hydroxylase at low stimulation frequencies by α-blocking agents. Arch Int Pharmacodyn Ther 193:191-197.
90. 3H]norepinephrine release from rat hippocampal slices. J Neurochem 63:231-237.
91. 3H]norepinephrine release in rat hippocampal slices. Neuropharmacology 34:141-147.
92. Descarries L, Beaudet A and Watkins KC (1975) Serotonin nerve terminals in adult rat neocortex. Brain Res 100:563-588.
93. Descarries L, Bosler O, Berthelet F and Des Rosiers MH (1980) Dopaminergic nerve endings visualised by high-resolution autoradiography in adult rat neostriatum. Nature (Lond) 284:620-622.
94. Descarries L, Gisiger V and Steriade M (1997) Diffuse transmission by acetylcholine in the CNS. Prog Neurobiol 53:603-625.
95. Descarries L, Lemay B, Doucet G and Berger B (1987) Regional and laminar density of the dopamine innervation in adult rat cerebral cortex. Neuroscience 21:807-824.
96. Descarries L, Séguéla P and Watkins KC (1991) Nonjunctional relationships of monoamine axon terminals in the cerebral cortex of adult rat, in Volume Transmission in the Brain (Fuxe K and Agnati LF eds) pp 53-62, Raven Press, New York.
97. Descarries L, Soucy JP, Lafaille F, Mrini A and Tanguay R (1995) Evaluation of three transporter ligands as quantitative markers of serotonin innervation density in rat brain. Synapse 21:131-139.
98. Descarries L, Watkins KC and Lapierre Y (1977) Noradrenergic axon terminals in the cerebral cortex of the rat. III. Topometric ultrastructural analyses. Brain Res 133:197-222.
99. Destexhe A and Sejnowski TJ (1995) G protein activation kinetics and spillover of γ-aminobutyric acid may account for differences between inhibitory responses in the hippocampus and thalamus. Proc Natl Acad Sci USA 92:9515-9519.
100. 2 adrenergic receptor subtypes. J Pharmacol Exp Ther 278:1215-1227.
101. 2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum. J Neurochem 72:148-156.
102. Dingledine R, Borges K, Bowie D and Traynelis SF (1999) The glutamate receptor ion channels. Pharmacol Rev 51:7-51.
103. Dingledine R and Korn SJ (1985) γ-Aminobutyric acid uptake and the termination of inhibitory synaptic potentials in the rat hippocampal slice. J Physiol (Lond) 366:387-409.
104. Doucet G, Descarries L and Garcia S (1986) Quantification of the dopamine innervation in adult rat neostriatum. Neuroscience 19:427-445.
105. Dunnett SB, Everitt BJ and Bobbins TW (1991) The basal forebrain-cortical cholinergic system: Interpreting the functional consequences of excitotoxic lesions. Trends Neurosci 14:494-500.
106. During MJ, Ryder KM and Spencer DD (1995) Hippocampal GABA transporter function in temporal-lobe epilepsy. Nature (Lond) 376:174-177.
107. Ehinger B, Falck B and Sporrong B (1970) Possible axo-axonal synapses between peripheral adrenergic and cholinergic nerve terminals. Z Zellforsch 107:508-521.
108. Elliott TR (1904) On the action of adrenaline. J Physiol (Lond) 31:20-21.
109. Elenkov IJ and Vizi ES (1991) Presynaptic modulation of release of noradrenaline from the sympathetic nerve terminals in the rat spleen. Neuropharmacology 12:1319-1324.
110. 1B binding sites. Naunyn-Schmiedeberg's Arch Pharmacol 332: 1-7.
111. Erecinska M (1997) The neurotransmitter amino acid transport systems: A fresh outlook of an old problem. Biochem Pharmacol 36:3547-3555.
112. Erulkar SD and Rahamimoff R (1978) The role of calcium ions in tetanic and post-tetanic increase in miniature endplate potential frequency. J Physiol (Lond) 278:501-511.
113. 3H]-noradrenaline from field stimulated rat iris. Br J Pharmacol 43:97-106.
114. 3H-monoamines from field stimulated rat brain slices. Acta Physiol Scand Suppl 371:35-44.
115. 3H]glutamate release from rat hippocampal slices by L-phenylisopropyladenosine. Acta Physiol Scand 125:121-123.
116. Felder CC (1995) Muscarinic acetylcholine receptors: Signal transduction through multiple effectors. FASEB J 9:619-625.
117. 2-adrenoceptors on serotonergic nerve endings in human and rat neocortex. J Neurochem 61:474-480.
118. Floor E, Leventhal PS, Wang Y, Meng L and Chen W (1995) Dynamic storage of dopamine in rat brain synaptic vesicles in vitro. J Neurochem 64:689-699.
119. 1 dopamine receptors stimulates the release of GABA in the basal ganglia of the rat. Neurosci Lett 116:136-140.
120. 2 receptor-mediated inhibition of GABA release by endogenous dopamine in the rat globus pallidus. Neurosci Lett 237:1-4.
121. Frank K and Fuortes MGF (1951) Presynaptic and postsynaptic inhibition of nonsynaptic reflexes. Fed Proc 16:39-40.
122. Fredholm BB (1976) Release of adenosine-like material from isolated perfused dog adipose tissue following sympathetic nerve stimulation and its inhibition by adrenergic α-receptor blockade. Acta Physiol Scand 96:422-430.
123. Fredholm BB and Dunwiddie TV (1988) How does adenosine inhibit transmitter release? Trends Pharmacol Sci 9:130-134.
124. Freund TF and Buzsáki G (1996) Interneurons of the hippocampus. Hippocampus 6:347-470.
125. A-receptors in temporal lobe epilepsy. Neurochem Int 34:435-445.
126. Fung SC and Fillenz M (1983) The role of presynaptic GABA and benzodiazepine receptors in the control of noradrenaline release in rat hippocampus. Neurosci Lett 42:61-66.
127. Fuxe K and Agnati LF (1991) Two principal modes of electrochemical communication in the brain: Volume versus wiring transmission, in Volume Transmission in the Brain: Novel Mechanisms for Neural Transmission (Fuxe K and Agnati LF eds) pp 1-10, Raven Press, New York.
128. Gainetdinov RR, Jones SR, Fumagalli F, Wightman RM and Caron MG (1998) Re-evaluation of the role of the dopamine transporter in dopamine system homeostasis. Brain Res Rev 26:148-153.
129. Gally JA, Montague PR, Reeke GN Jr and Edelman GM (1990) The NO hypothesis: Possible effects of a short-lived, rapidly diffusible signal in the development and function of the nervous system. Proc Natl Acad Sci USA 87:3547-3551.
130. 3H]hydroxytryptamine in slices of the human neocortex. J Neurochem 59:1293-1301.
131. i coupling proteins and regulatory receptor kinases in the prefrontal cortex of depressed suicides. J Neurochem 72:282-291.
132. 2-adrenoceptors in major affective disorder. Arch Gen Psychiatry 43:51-57.
133. Garcia-Sevilla JA, Udina C, Alvarez E and Casas M (1987) Enhanced binding of clomipramine treatment. Acta Psychiatr Scand 75:150-157.
134. 2-adrenergic receptors in major depressive disorder. Arch Gen Psychiatry 38:1327-1333.
135. Garthwaite J and Boulton CL (1995) Nitric oxide signalling in the central nervous system. Annu Rev Physiol 57:683-706.
136. Garthwaite J, Charles SL and Chess-Williams R (1988) Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature (Lond) 336:385-388.
137. Geiger JR, Lubke J, Roth A, Frotscher M and Jonas P (1997) Submillisecond AMPA receptor-mediated signalling at a principal neuron-interneuron synapse. Neuron 18:1009-1023.
138. Gelagashvili G and Schousboe A (1998) Cellular distribution and kinetic properties of high-affinity glutamate transporters. Brain Res Bull 45:233-238.
139. Giacobini E (1998) Invited review: Cholinesterase inhibitors for Alzheimer's disease therapy: from tacrine to future applications. Neurochem Int 32:413-419.
140. Giros B, Jaber M, Jones SR, Wightman RM and Caron MG (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature (Lond) 379:606-612.
141. 2B-adrenoceptor subtype. Naunyn-Schmiedeberg's Arch Pharmacol 342:382-386.
142. Gonon FG and Buda MJ (1985) Regulation of dopamine release by impulse flow and by autoreceptors as studied by in vivo voltammetry in the rat striatum. Neuroscience 14:765-774.
143. Gordon-Weeks PR (1982) Noradrenergic and non-noradrenergic nerves containing small granular vesicles in Auerbach's plexus of the guinea-pig: Evidence against the presence of noradrenergic synapses. Neuroscience 7:2925-2936.
144. Göthert M and Schlicker E (1991) Regulation of serotonin release in the CNS by presynaptic heteroreceptors, in Presynaptic Regulation of Neurotransmitter Release (Feigenbaum J and Hanani M eds) pp 845-876, Springer-Verlag, Berlin/ Heidelberg/New York.
145. Göthert M and Schlicker E (1997) Regulation of 5-HT release in the CNS by presynaptic 5-HT autoreceptors and 5-HT heteroreceptors, in Serotonergic Neurons and 5-HT Receptors in the CNS (Baumgarten HG and Göthert M eds) pp 307-350, Springer-Verlag, Berlin/Heidelberg/New York.
146. 3H]dopamine release from mouse striatal synaptosomes. J Neurochem 62:1390-1398.
147. Graefe K-H and Bönisch H (1988) The transport of amines across the axonal membranes of noradrenergic and dopaminergic neurons, in Handbook of Experimental Pharmacology, Vol 90. Catecholamines I (Trendelenburg U and Weiner N eds) pp 193-245, Springer-Verlag, Berlin/Heidelberg/New York.
148. Gray R, Rajan AS, Radcliffe KA, Yakehiro M and Dani JA (1996) Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature (Lond) 383:713-716.
149. 3H]RX-821002 binding to membranes and tissue sections. Eur J Pharmacol 310:83-93.
150. Gu JGG and MacDermott AB (1997) Activation of ATP P2X receptors elicits glutamate release from sensory neuron synapses. Nature (Lond) 389:749-753.
151. 2A-autoreceptors in the human gastric and ileocolic arteries. Naunyn-Schmiedeberg's Arch Pharmacol 358:207-211.
152. Gulyás AI, Acsady L and Freund TF (1999) Structural basis of the cholinergic and serotonergic modulation of GABAergic neurons in the hippocampus. Neurochem Int 34:359-372.
153. Harder JA, Baker HF and Ridley RM (1998) The role of the central cholinergic projections in cognition: Implications of the effect of scopolamine on discrimination learning in monkeys. Brain Res Bull 45:319-326.
154. 3H]noradrenaline from slices of rat brain neocortex. Eur J Pharmacol 49:305-308.
155. 2 interactions and nonsynaptic influences. Neuroscience 77:419-429.
156. Haskó G, Elenkov IJ and Vizi ES (1995) Presynaptic receptors involved in the modulation of release of noradrenaline from the sympathetic nerve terminals of the rat thymus. Immunol Lett 47:133-137.
157. Hasselmo ME and Barkai E (1995) Cholinergic modulation of activity-dependent synaptic plasticity in the piriform cortex and associative memory function in a network biophysical simulation. J Neurosci 15:6592-6604.
158. Hasselmo ME and Bower JM (1992) Cholinergic suppression specific to intrinsic not afferent fiber synapses in rat piriform (olfactory) cortex. J Neurophysiol 67:1222-1229.
159. Hasselmo ME and Bower JM (1993) Acetylcholine and memory. Trends Neurosci 16:218-222.
160. Hasselmo ME and Schnell E (1994) Laminar selectivity of the cholinergic suppression of synaptic transmission in rat hippocampal region CA1: Computational modeling and brain slice physiology. J Neurosci 14:3898-3914.
161. 3H]dopamine in rat brain tissue slices. Biochem Pharmacol 24:847-852.
162. 3H]norepinephrine in slices of rat neostriatum and cerebral cortex. J Pharmacol Exp Ther 194:47-56.
163. Henry JP, Sagne C, Bedet C and Gasnier B (1998) The vesicular monoamine transporter: From chromaffin granule to brain. Neurochem Int 32:227-246.
164. Herkenham M (1987) Mismatches between neurotransmitter and receptor localization in brain: Observations and implications. Neuroscience 23:1-38.
165. Herkenham M (1991) Mismatches between neurotransmitter and receptor localization: Implications for endocrine functions in the brain, in Volume Transmission in the Brain: Novel Mechanisms for Neural Transmission (Fuxe K and Agnati LF eds) pp 63-87, Raven Press, New York.
166. A receptor, modulates glutamate release from rat cortical neurons in culture. Neurochem Int 34:141-148.
167. Hille B (1992) G protein-coupled mechanisms and nervous signaling. Neuron 9:187-195.
168. Hoffman BJ, Hansson SR, Mezey E and Palkovits M (1998) Localization and dynamic regulation of biogenic amine transporters in the mammalian central nervous system. Front Neuroendocrinol 19:187-231.
169. Hoffmann IS and Cubeddu LX (1984) Differential effects of bromocriptine on dopamine and acetylcholine release modulatory receptors. J Neurochem 42:278-282.
170. Holthoff K and Witte OW (1998) Intrinsic optical signals in vitro: A tool to measure alterations in extracellular space with two-dimensional resolution. Brain Res Bull 47:649-655.
171. 4 and 5-HT-M receptors. Neuropsychopharmacology 3:371-383.
172. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR and Humphrey PP (1994) International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46:157-203.
173. Hyttel J (1982) Citalopram: Pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog Neuropsychopharmacol Biol Psych 6:277-295.
174. Ikarashi Y, Takahashi A, Ishimaru H, Shiobara T and Maruyama Y (1998) The role of nitric oxide in striatal acetylcholine release induced by N-methyl-D-aspartate. Neurochem Int 33:255-261.
175. Isaacson JS, Solis JM and Nicoll RA (1993) Local and diffuse synaptic actions of GABA in the hippocampus. Neuron 10:165-175.
176. Iversen LL and Kelly JS (1975) Uptake and metabolism of γ-aminobutyric acid by neurons and glial cells. Biochem Pharmacol 24:933-938.
177. 2-heteroreceptor function. Brain Res Bull 48:49-59.
178. Jackisch R, Stemmelin J, Neufang B, Lauth D, Neughebauer B, Kelche C and Cassel JC (1999b) Sympathetic sprouting: No evidence for muscarinic modulation of noradrenaline release in hippocampal slices of rats with fimbria-fornix lesions. Exp Brain Res 124:17-24.
179. Jackisch R, Strittmatter H, Kasakov L and Hertting G (1984) Endogenous adenosine as a modulator of hippocampal acetylcholine release. Naunyn-Schmiedeberg's Arch Pharmacol 327:319-325.
180. Jensen JB, Schousboe A and Pickering DS (1998) AMPA receptor mediated excitotoxicity in neocortical neurons is developmentally regulated and dependent upon receptor desensitization. Neurochem Int 32:505-513.
181. Kalsner S and Westfall TC (eds) (1990) Presynaptic receptors and the question of autoregulation of neurotransmitter release. Ann NY Acad Sci 604:1-652.
182. Kamisaki Y, Hamahashi T, Hamada T, Maeda K and Ito T (1992) Presynaptic inhibition by clonidine of neurotransmitter amino acid release in various brain regions. Eur J Pharmacol 217:57-63.
183. Kanner BI and Schuldiner BI (1987) Mechanism of transport and storage of neurotransmitters. CRC Crit Rev Biochem 22:1-38.
184. Kardos J (1999) Recent advances in GABA research. Neurochem Int 34:353-358.
185. 2-adrenoceptor-mediated inhibition of hypothalamic norepinephrine release. J Neurosci 13:3448-3455.
186. Kása P, Hlavati I, Dobo E, Wolff A, Joo F and Wolff JR (1995) Synaptic and non-synaptic cholinergic innervation of the various types of neurons in the main olfactory bulb of adult rat: Immunocytochemistry of choline acetyltransferase. Neuroscience 67:667-677.
187. Kása P, Rakonczay Z and Gulya K (1997) The cholinergic system in Alzheimer's disease. Prog Neurobiol 62:511-535.
188. Katz B (1969) The release of neural transmitter substances. Liverpool University Press, Liverpool.
189. Katz B and Miledi R (1973a) The binding of acetylcholine to receptors and its removal from the synaptic cleft. J Physiol (Lond) 231:549-754.
190. Katz B and Miledi R (1973b) The effect of atropine on acetylcholine action at the neuromuscular junction. Proc R Soc Lond B Biol Sci 184:221-226.
191. Katz B and Miledi R (1977) Transmitter leakage from motor nerve endings. Proc R Soc Lond B Biol 196:59-72.
192. 2+ concentration in isolated nerve terminals following metabolic inhibition: possible relevance to hypoglycaemia and anoxia. Neuroscience 27:175-182.
193. Kawagoe KT, Garris PA, Wiedemann DJ and Wightman RM (1992) Regulation of transient dopamine concentration gradients in the microenvironment surrounding nerve terminals in the rat striatum. Neuroscience 51:55-64.
194. Keverne EB (1999) GABAergic neurons and the neurobiology of schizophrenia and other psychoses. Brain Res Bull 48:467-471.
195. Khakh BS and Henderson G (1998) ATP receptor mediated enhancement of fast excitatory neurotransmitter release in the brain. Mol Pharmacol 54:372-378.
196. Khakh BS and Kennedy C (1998) Adenosine and ATP: progress in their receptors' structures and functions. Trends Pharmacol Sci 19:39-41.
197. 1A receptors in the rat brain. J Neurosci Res 46:697-708.
198. Kilbinger H, Dietrich C and von Bardeleben RS (1993) Functional relevance of presynaptic muscarinic autoreceptors. J Physiol (Paris) 87:77-81.
199. 3-receptors. Med Res Rev 10:441-475.
200. 3H]acetylcholine release. J Neurochem 62:960-966.
201. Kiss JP, Hennings ECP, Zsilla G and Vizi ES (1999a) A possible role of nitric oxide in the regulation of dopamine transporter function in the striatum. Neurochem Int 34:345-350.
202. Kiss JP, Sershen H, Lajtha A and Vizi ES (1996) Inhibition of neuronal nitric oxide synthase potentiates the dimethylphenylpiperazinium-evoked carrier-mediated release of noradrenaline from rat hippocampal slices. Neurosci Lett 215:115-118.
203. Kiss JP, Vizi ES and Westerink BH (1999b) Effect of neostigmine on the hippocampal noradrenaline release: Role of cholinergic receptors. Neuroreport 10:81-86.
204. 2-adrenoceptors modulating hippocampal norepinephrine release in rat. Brain Res 674:238-244.
205. Koch H, von Kügelgen I and Starke K (1997) P2-receptor-mediated inhibition of noradrenaline release in the rat hippocampus. Naunyn-Schmiedeberg's Arch Pharmacol 355:707-715.
206. Koelle GB (1990) Early evidence of presynaptic receptors. Ann NY Acad Sci 604: 488-491.
207. Kuffler SW and Yoshikami D (1975) The number of transmitter molecules in a quantum: An estimate from iontophoretic application of acetylcholine at the neuromuscular synapse. J Physiol (Lond) 251:465-482.
208. Kuhar MJ, Ritz MC and Boja JW (1991) The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci 14:299-302.
209. Kulak JM, Nguyen TA, Olivera BM and McIntosh JM (1997) α-Conotoxin MII blocks nicotine-stimulated dopamine release in rat striatal synaptosomes. J Neurosci 17:5263-5270.
210. Kullmann DM and Asztely F (1998) Extrasynaptic glutamate spillover in the hippocampus: Evidence and implications. Trends Neurosci 21:8-14.
211. Kullmann DM, Erdemli G and Asztely F (1996) LTP of AMPA and NMDA receptor-mediated signals: Evidence for presynaptic expression and extrasynaptic glutamate spill-over. Neuron 17:461-474.
212. Kuo M-F, Song D, Murphy S, Papadopoulos MD, Wilson DF and Pastuszko A (1998) Excitatory amino acid receptor antagonists decrease hypoxia induced increase in extracellular dopamine in striatum of newborn piglets. Neurochem Int 32:281-289.
213. 2 receptors to increase potassium conductance in neurons of the rat substantia nigra zona compacta. J Physiol (Lond) 392:397-416.
214. Langer SZ (1974) Presynaptic regulation of catecholamine release. Biochem Pharmacol 23:1793-1800.
215. Langer SZ (1977) Presynaptic receptors and their role in the regulation of transmitter release. Br J Pharmacol 60:481-497.
216. Langer SZ (1981a) Presynaptic regulation of the release of catecholamines. Pharmacol Rev 32:337-362.
217. 2-adrenoceptors in guinea-pig atria. Nature (Lond) 294:671-672.
218. Langer SZ (1997) 25 Years since the discovery of presynaptic receptors: present knowledge and future perspectives. Trends Pharmacol Sci 18:95-99.
219. Langer SZ, Scatton B, Schoemaker H and Rein W (1998) Presynaptic autoreceptors and heteroreceptors are both alive and kicking. Trends Pharmacol Sci 19:128-131.
220. 3H]AF-DX 116 and the effect of AF-DX 116 on endogenous acetylcholine release from rat brain slices. Brain Res 496:285-294.
221. 2 adrenergic receptor subtype in human spinal cord. Anesthesiology 77:983-991.
222. 2+ ions in nicotinic facilitation of GABA release in mouse thalamus. J Neurosci 17:576-585.
223. Lena C, Changeux JP and Mulle C (1993) Evidence for 'preterminal' nicotinic receptors of GABAergic axons in the rat interpeduncular nucleus. J Neurosci 13:2680-2688.
224. Lerma J, Herranz AS, Herreras D, Abraira V and Martin Del Rio R (1986) In vivo determination of extracellular concentration of amino acids in the rat hippocampus. Brain Res 384:145-155.
225. Lester HA, Cao Y and Mager S (1996) Listening to neurotransmitter transporters. Neuron 17:807-810.
226. Lester HA, Mager S, Quick MW and Corey JL (1994) Permeation properties of neurotransmitter transporters. Annu Rev Pharmacol Toxicol 34:219-249.
227. Lester RA and Jahr CE (1990) Quisqualate receptor-mediated depression of calcium currents in hippocampal neurons. Neuron 4:741-749.
228. Levey AI, Edmunds SM, Koliatsos V, Wiley RG and Heilman CJ (1995) Expression of m1-m4 muscarinic acetylcholine receptor proteins in rat hippocampus and regulation by cholinergic innervation. J Neurosci 15:4077-4092.
229. Levi G and Raiteri M (1976) Synaptosomal transport processes. Int Rev Neurobiol 19:51-74.
230. Levi G and Raiteri M (1993) Carrier-mediated release of neurotransmitters. Trends Neurosci 16:415-419.
231. Liang NY and Rutledge CO (1982) Evidence for carrier-mediated efflux of dopamine from corpus striatum. Biochem Pharmacol 31:2479-2484.
232. 1D in the rabbit and guinea-pig brain cortex. Naunyn-Schmiedeberg's Arch Pharmacol 343:353-364.
233. Lindmar R and Löffelholz K (1972) Differential effects of hypothermia on neuronal efflux, release and uptake of noradrenaline. Naunyn-Schmiedeberg's Arch Pharmacol 274:410-414.
234. Lindmar R, Löffelholz K and Muscholl E (1968) A muscarinic mechanism inhibiting the release of noradrenaline from peripheral adrenergic nerve fibers by nicotinic agents. Br J Pharmacol 32:280-294.
235. Llinas RR (1977) Depolarization-release coupling systems in neurons. Neurosci Res Prog Bull 15:555-687.
236. Loewi O (1921) Über humorale Übertragbarkeit der Herznervenwirkung. Pflügers Arch Gesamte Physiol 189:239-242.
237. 3H]glutamate by striatal synaptosomes. J Neurochem 63: 2108-2117.
238. 3H]norepinephrine release. I. The role of glutamate. J Pharmacol Exp Ther 275:7-13.
239. 3H]norepinephrine release. II. The role of calcium, reverse norepinephrine transport and cyclic 3′,5′-guanosine monophosphate. J Pharmacol Exp Ther 275:14-22.
240. Loy R, Koziell DA, Lindsey JD and Moore RY (1980) Noradrenergic innervation of the adult rat hippocampal formation. J Comp Neurol 189:699-710.
241. Löffelholz K and Muscholl E (1969a) A muscarinic inhibition of the noradrenaline release evoked by postganglionic sympathetic nerve stimulation. Naunyn-Schmiedeberg's Arch Pharmacol 265:1-15.
242. Loffelholz K and Muscholl E (1969b) Inhibitory effect of acetylcholine on the release of noradrenaline from isolated rabbit hearts stimulated sympathetically. Naunyn-Schmiedeberg's Arch Pharmacol 263:236-237.
243. Lu Y, Grady S, Marks MJ, Picciotto M, Changeux J-P and Collins AC (1998) Pharmacological characterization of nicotinic receptor-stimulated GABA release from mouse brain synaptosomes. J Pharmacol Exp Ther 287:648-657.
244. MacDermott AB, Role LW and Siegelbaum SA (1999) Presynaptic ionotropic receptors and the control of transmitter release. Annu Rev Neurosci 22:443-485.
245. 2 adrenoceptor-subtype function. Trends Pharmacol Sci 18:211-219.
246. Majewski H, Costa M, Foucart S, Murphy T and Musgrave IF (1990) Second messengers are involved in facilitatory but not inhibitory receptor actions at sympathetic nerve ending. Ann NY Acad Sci 604:266-275.
247. Majewski H and Iannazzo L (1998) Protein kinase C: A physiological mediator of enhanced transmitter output. Prog Neurobiol 55:463-475.
248. 2+ concentration mediated by transport of glutamate into rat hippocampal synaptosomes: Characterization of the activated voltage sensitive Ca channels. Neurochem Int 32:7-16.
249. Malva JO, Carvalho AP and Carvalho CM (1996) Domoic acid induces the release of glutamate in the rat hippocampal CA3 subregion. Neuroreport 7:1330-1334.
250. Malva JO, Carvalho AP and Carvalho CM (1998a) Kainate receptors in hippocampal CA3 subregion: Evidence for a role in regulating neurotransmitter release. Neurochem Int 32:1-6.
251. Manber L and Gershon MD (1979) A reciprocal adrenergic-cholinergic axo-axonic synapse in the mammalian gut. Am J Physiol 236:738-745.
252. 2+ ions in their function and desensitization. Neurochem Int 34:319-328.
253. 3H]serotonin release in different rat brain areas. Eur J Pharmacol 129:353-357.
254. Marchi M and Raiteri M (1989) Interaction acetylcholine-glutamate in rat hippocampus: involvement of two subtypes of M-2 muscarinic receptors. J Pharmacol Exp Ther 248:1255-1260.
255. Marshal DL, Soliakov L, Redfern P and Wonnacott S (1996) Tetrodotoxin-sensitivity of nicotine-evoked dopamine release from rat striatum. Neuropharmacology 35: 1531-1536.
256. 3 receptors in the control of 5-HT release in rat hippocampus in vivo. Br J Pharmacol 106:139-142.
257. Masland RL and Wigton RS (1940) J Neurophysiol 3:269-275.
258. 2-adrenoceptors in the locus coeruleus are involved in the in vivo modulation of cortical noradrenaline release by the antidepressant desipramine. J Neurochem 71:790-798.
259. Matthews-Bellinger J and Salpeter MM (1978) Distribution of acetylcholine receptors at frog neuromuscular junctions with a discussion of some physiological implications. J Physiol (Lond) 279:197-213.
260. 1B receptors mediating inhibition of acetylcholine release. Eur J Pharmacol 129:333-337.
261. 1 receptor. Naunyn-Schmiedeberg's Arch Pharmacol 334:323-326.
262. 1D autoreceptors in human cerebral cortex. J Neurochem 60:1179-1182.
263. McBain CJ, Traynelis SF and Dingledine R (1990) Regional variation of extracellular space in the hippocampus. Science (Wash DC) 249:674-677.
264. McGehee DS, Heath MJ, Gelber S, Devay P and Role LW (1995) Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science 269:1692-1696.
265. McGehee DS and Role LW (1996) Presynaptic ionotropic receptors. Curr Opin Neurobiol 6:342-349.
266. McKinney M, Miller JH and Aagaard PJ (1993) Pharmacological characterization of the rat hippocampal muscarinic autoreceptor. J Pharmacol Exp Ther 264:74-78.
267. McLean S, Rothman RB, Jacobson AE, Rice KC and Herkenham M (1987) Distribution of opiate receptor subtypes and enkephalin and dynorphin immunoreactivity in the hippocampus of squirrel, guinea pig, rat and hamster. J Comp Neurol 255:497-510.
268. McMillen BA, Warnack W, German DC and Shore PA (1980) Effects of chronic desipramine treatment on rat brain noradrenergic responses to α-adrenergic drugs. Eur J Pharmacol 61:239-246.
269. 2 receptors may modulate the function of the striatal transporter for dopamine: Kinetic evidence from studies in vitro and in vivo. J Neurochem 61:764-767.
270. Miller KJ and Hoffman BJ (1994) Adenosine A3 receptors regulate serotonin transport via nitric oxide and cGMP. J Biol Chem 269:27351-27356.
271. Milusheva E, Baranyi M, Zelles T, Mike A and Vizi ES (1994) Release of acetylcholine and noradrenaline from the cholinergic and adrenergic afferents in rat hippocampal CA1, CA3 and dentate gyrus regions. Eur J Neurosci 6:187-192.
272. 3H]dopamine in rat striatal slices. Neurochem Int 28:501-507.
273. Milusheva EA, Doda M, Pasztor E, Lajtha A, Sershen H and Vizi ES (1992) Regulatory interactions among axon terminals affecting the release of different transmitters from rat striatal slices under hypoxic and hypoglycemic conditions. J Neurochem 59:946-952.
274. B receptors and the effects of baclofen in the mammalian central nervous system. Prog Neurobiol 46:423-462.
275. Missale C, Nash SR, Robinson SW, Jaber M and Caron MG (1998) Dopamine receptors: From structure to function. Physiol Rev 78:189-225.
276. Mitchell JB, Lupica CR and Dunwiddie TV (1993) Activity-dependent release of endogenous adenosine modulates synaptic responses in the rat hippocampus. J Neurosci 13:3439-3447.
277. Mody I, De Koninck Y, Otis TS and Soltesz I (1994) Bridging the cleft at GABA synapses in the brain. Trends Neurosci 17:517-525.
278. Moncada S, Higgs A and Furchgott R (1997) XIV. International Union of Pharmav cology nomenclature in nitric oxide research. Pharmacol Rev 49:137-142.
279. Mongeau R, Blier P and de Montigny C (1997) The serotonergic and noradrenergic systems of the hippocampus: Their interactions and the effects of antidepressant treatments. Brain Res Rev 23:145-195.
280. Montague PR and Gancayco CD, Winn MJ, Marchase RB, Friedlander MJ (1994) Role of NO production in NMDA receptor-mediated neurotransmitter release in cerebral cortex. Science (Wash DC) 263:973-977.
281. Moor E, DeBoer P, Auth F and Westerink BH (1995) Characterisation of muscarinic autoreceptors in the septo-hippocampal system of the rat: A microdialysis study. Eur J Pharmacol 294:155-161.
282. Morari M, Marti M, Sbrenna S, Fuxe K, Bianchi C and Beani L (1998) Reciprocal dopamine-glutamate modulation of release in the basal ganglia. Neurochem Int 33:383-397.
283. 2a receptors in regulating GABAergic synaptic transmission in striatal medium spiny neurons. J Neurosci 16:605-611.
284. Morton RA and Davies CH (1997) Regulation of muscarinic acetylcholine receptor-mediated synaptic responses by adenosine receptors in the rat hippocampus. J Physiol (Lond) 502:76-90.
285. Murphy DL, Wichems C, Li Q and Heils A (1999) Molecular manipulations as tools for enhancing our understanding of 5-HT neurotransmission. Trends Pharmacol Sci 20:246-252.
286. Muscettola G, Goodwin FK, Potter WZ, Claeys MM and Markey SP (1978) Imipramine and desipramine in plasma and spinal fluid: Relationship to clinical response and serotonin metabolism. Arch Gen Psychiatry 35:621-625.
287. Muscholl E (1980a) Presynaptic muscarinic control of noradrenaline release, in Modulation of Neurochemical Transmission (Vizi ES ed) pp 1-12, Pergamon Press, Oxford/Akadémiai Kiadó, Budapest.
288. Muscholl E (1980b) Peripheral muscarinic control of norepinephrine release in the cardiovascular system. Am J Physiol 239:713-720.
289. 3H]noradrenaline and glutamate in response to simulation of ischemic conditions in rat spinal cord slice preparation: Effect of NMDA and AMPA receptor antagonists. Eur J Pharmacol 366:143-150.
290. - neurotransmitter transporters. J Neurochem 71:1785-1803.
291. Nicholls D and Attwell D (1990) The release and uptake of excitatory amino acids. Trends Pharamcol Sci 11:462-468.
292. Nicholson A and Rice ME (1991) Diffusion of ions and transmitters in the brain cell microenvironment, in Volume Transmission in the Brain: Novel Mechanisms for Neural Transmission (Fuxe K and Agnati LF eds) pp 279-294, Raven Press, New York.
293. Nicholson C (1985) Diffusion from an injected volume of a substance in brain tissue with arbitrary volume fraction and tortuosity. Brain Res 333:325-329.
294. Nicholson C and Syková E (1998) Extracellular space structure revealed by diffusion analysis. Trends Neurosci 21:207-215.
295. Nicoll RA and Alger BE (1979) Presynaptic inhibition: Transmitter and ionic mechanism. Int Rev Neurobiol 21:217-258.
296. Nirenberg MJ, Chan J, Pohorille A, Vaughan RA, Uhl GR, Kuhar MJ and Pickel VM (1997) The dopamine transporter: Comparative ultrastructure of dopaminergic axons in limbic and motor compartments of the nucleus accumbens. J Neurosci 17:6899-6907.
297. Nirenberg MJ, Vaughan RA, Uhl GR, Kuhar MJ and Pickel VM (1996) The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons. J Neurosci 16:436-447.
298. 2 receptors mediate depolarization and presynaptic inhibition in guinea-pig enteric nervous system. J Physiol (Lond) 368:435-452.
299. Nusser Z (1999) A new approach to estimate the number, density and variability of receptors at central synapses. Eur J Neurosci 11:745-752.
300. Nusser Z, Hajos N, Somogyi P and Mody I (1998a) Increased number of synaptic GABAA receptors underlies potentiation at hippocampal inhibitory synapses. Nature (Lond) 395:172-177.
301. Nusser Z, Sieghart W and Somogyi P (1998b) Segregation of different GABAA receptors to synaptic and extrasynaptic membranes of cerebellar granule cells. J Neurosci 18:1693-1703.
302. Ohno K, Okada M, Tsutsumi R, Matsumoto N and Yamaguchi T (1998) Characterization of cyclothiazide-enhanced kainate excitotoxicity in rat hippocampal cultures. Neurochem Int 32:265-271.
303. Oleskevich S, Descarries L and Lacaille JC (1989) Quantified distribution of the noradrenaline innervation in the hippocampus of adult rat. J Neurosci 9:3803-3815.
304. Oleskevich S, Descarries L, Watkins KC, Seguela P and Daszuta A (1991) Ultrastructural features of the serotonin innervation in adult rat hippocampus: an immunocytochemical description in single and serial thin sections. Neuroscience 42:777-791.
305. Onali P, Olianas MC and Gessa GL (1985) Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum. Mol Pharmacol 28:138-145.
306. Osawa I, Saito N, Koga T and Tanaka C (1994) Phorbol ester-induced inhibition of GABA uptake by synaptosomes and by Xenopus oocytes expressing GABA transporter (GAT1). Neurosci Res 19:287-293.
307. Page G, Chalon S, Barrier L, Piriou A and Huguet F (1998) Characterization of both dopamine uptake systems in rat striatal slices by specific pharmacological tools. Neurochem Int 33:459-466.
308. 3H]noradrenaline release in rat brain cortical and hippocampal synaptosomes. Neurosci Lett 216:187-190.
309. Patel DR and Croucher MJ (1997) Evidence for a role of presynaptic AMPA receptors in the control of neuronal glutamate release in the rat forebrain. Eur J Pharmacol 332:143-151.
310. Pato MT, Murphy DL and DeVane CL (1991) Sustained plasma concentrations of fluoxetine and/or norfluoxetine four and eight weeks after fluoxetine discontinuation. J Clin Psychopharmacol 11:224-225.
311. Paton WDM and Vizi ES (1969) The inhibitory action of noradrenaline and adrenaline on acetylcholine output by guinea-pig ileum longitudinal muscle strip. Br J Pharmacol 35:10-28.
312. Pazos A, Cortés R and Palacios JM (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors. Brain Res 346:231-249.
313. Pazos A and Palacios JM (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res 346:205-230.
314. B) receptor subtype. Brain Res 604: 325-330.
315. 3 receptors. Trends Pharmacol Sci 13:391-397.
316. 3H]dopamine release from rat mesencephalic cells in primary culture. J Neurochem 64:1410-1412.
317. Piguet P and Galvan M (1994) Transient and long-lasting actions of 5-HT on rat dentate gyrus neurons in vitro. J Physiol (Lond) 481:629-639.
318. 2-adrenoceptors in depressive illness. Life Sci 39:1589-1616.
319. Pin JP and Bockaert J (1989) Two distinct mechanisms, differentially affected by excitatory amino acids, trigger GABA release from fetal mouse striatal neurons in primary culture. J Neurosci 9:648-656.
320. B type. Eur J Pharmacol 144:45-52.
321. Pittaluga A, Bonfanti A and Raiteri M (1997) Differential desensitization of ionotropic non-NMDA receptors having distinct neuronal location and function. Naunyn-Schmiedeberg's Arch Pharmacol 356:29-38.
322. Pittaluga A, Pattarini R, Severi P and Raiteri M (1996) Human brain N-methyl-D-aspartate receptors regulating noradrenaline release are positively modulated by HIV-1 coat protein gp120. AIDS 10:463-468.
323. Pittaluga A and Raiteri M (1992a) N-Methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. III. Changes in the NMDA receptor complex induced by their functional cooperation. J Pharmacol Exp Ther 263:327-333.
324. Pittaluga A and Raiteri M (1990b) Release-enhancing glycine-dependent presynaptic NMDA receptors exist on noradrenergic terminals of hippocampus. Eur J Pharmacol 191:231-234.
325. 3H]dopamine uptake. Brain Res 641:83-91.
326. 3H]glutamate transport in synaptosomes. Synapse 18:21-26.
327. Poncer JC, Shinozaki H and Miles R (1995) Dual modulation of synaptic inhibition by distinct metabotropic glutamate receptors in the rat hippocampus. J Physiol (Lond) 485:121-134.
328. 2A receptor stimulation enhances striatal extracellular glutamate levels in rats. Eur J Pharmacol 287:215-217.
329. Privat A, Mansour H and Geffard M (1988) Transplantation of fetal serotonin neurons into the transected spinal cord of adult rats: Morphological development and functional influence. Prog Brain Res 78:155-166.
330. Qian Y, Galli A, Ramamoorthy S, Risso S, DeFelice LJ and Blakely RD (1997) Protein kinase C regulates human serotonin transporters via altered surface expression in stably transfected HEK-293 cells. J Neurosci 17:45-57.
331. 2-muscarinic receptor antagonist in aged memory-impaired rats. J Neurosci 15:1455-1462.
332. 2-autoreceptors in human brain cortex. Br J Pharmacol 107:1146-1151.
333. Raiteri M, Marchi M and Paudice P (1990c) Presynaptic muscarinic receptors in the central nervous system. Ann N Y Acad Sci 604:113-129.
334. Raiteri M, Marchi M, Paudice P and Pittaluga A (1990a) Muscarinic receptors mediating inhibition of γ-aminobutyric acid release in rat corpus striatum and their pharmacological characterization. J Pharmacol Exp Ther 254:496-501.
335. 2-adrenoceptors in the human cerebral cortex. Naunyn-Schmiedeberg's Arch Pharmacol 342:508-512.
336. Ralevic V and Burnstock G (1998) Receptors for purines and pyrimidines. Pharmacol Rev 50:413-492.
337. Ramamoorthy S, Giovanetti E, Quian Y and Blakely RD (1998) Phosphorylation and regulation of antidepressant-sensitive serotonin transporters. J Biol Chem 273: 2458-2466.
338. Ramon-y-Cajal S (1893) Sur les ganglions et plexus de l'intestin. C R Soc Biol (Paris) 5:217-223.
339. Reader TA and Dewar KM (1999) Effects of denervation and hyperinnervation on dopamine and serotonin systems in the rat neostriatum implications for human Parkinson's disease. Neurochem Int 34:1-22.
340. 3 receptors. Br J Pharmacol 99:753-761.
341. 2 receptors in the rat central nervous system. Neuroscience 30:767-777.
342. Ridet JL, Rajaofetra N, Teilhac JR, Geffard M and Privat A (1993) Evidence for nonsynaptic serotonergic and noradrenergic innervation of the rat dorsal horn and possible involvement of neuron-glia interactions. Neuroscience 52:143-157.
343. Ritz MC, Lamb RJ, Goldberg SR and Kuhar MJ (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science (Wash DC) 237:1219-1223.
344. Rocha BA, Fumagalli F, Gainetdinov RR, Jones SR, Ator R, Giros B, Miller GW and Caron MG (1998) Cocaine self-administration in dopamine-transporter knockout mice. Nat Neurosci 1:132-137.
345. Rogers M, Colquhoun LM, Patrick JW and Dani JA (1997) Calcium flux through predominantly independent purinergic ATP and nicotinic receptors. J Neurophysiol 77:1407-1417.
346. Ross SB (1991) Synaptic concentration of dopamine in the mouse striatum in relationship to the kinetic properties of the dopamine receptors and uptake mechanism. J Neurochem 56:22-29
347. Rothman RB, Herkenham M, Pert CB, Liang T and Cascieri MA (1984) Visualization of rat brain receptors for the neuropeptide, substance P. Brain Res 309: 47-54.
348. Routtenberg A (1991) Action at a distance: the extracellular spread of chemicals in the nervous system, in Volume Transmission in the Brain (Fuxe K and Agnati LF eds) pp 295-298, Raven Press, New York.
349. Rudnick G and Wall SC (1992) The molecular mechanism of ecstasy [3.4-ethylene-dioxy-methamphetamine (MDMA)] 190 serotonin transporters are targets for MDMA-induced serotonin release. Proc Natl Acad Sci USA 89:1817-1821.
350. Rusakov DA, Kullman DM and Stewart MG (1999) Hippocampal synapses: Do they talk to their neighbours? Trends Neurosci 22:382-388.
351. Sandor NT, Brassai A, Puskas A and Lendvai B (1995) Role of nitric oxide in modulating neurotransmitter release from rat striatum. Brain Res Bull 36:483-486.
352. Sarantis M, Everett K and Attwell D (1988) A presynaptic action of glutamate at the cone output synapse. Nature (Lond) 332:451-453.
353. 2A adrenoceptors and Gi proteins in the human brain: Ratio of high-affinity agonist sites to antagonist sites and effect of age. J Pharmacol Exp Ther 269:1062-1072.
354. 2A-subtype. J Neurochem 63: 1077-1085.
355. Sato K, Windisch K, Matko I and Vizi ES (1999) Effects of non-depolarizing neuromuscular blocking agents on norepinephrine release from human atrial tissue obtained during cardiac surgery. Br J Anaesth 82:904-909.
356. Scanziani M, Salin PA, Vogt KE, Malenka RC and Nicoll RA (1997) Use-dependent increases in glutamate concentration activate presynaptic metabotropic glutamate receptors. Nature (Lond) 385:630-634.
357. Schmitt FO (1984) Molecular regulators of brain function: A new view. Neuroscience 13:991-1001.
358. Schneider JS, Rothblat DS and DiStefano L (1994) Volume transmission of
359. 3H]Noradrenaline release from brain slices induced by an increase in the intracellular sodium concentration: Role of intracellular calcium stores. J Neurochem 40:615-621.
360. 3H]-noradrenaline release from rat brain cortex slices. J Neurochem 46:1711-1717.
361. B receptors: Cerebellar granule cells as a model system. Neurochem Int 34:373-377.
362. Schloss P and Williams DC (1998) The serotonin transporter: A primary target for antidepressant drugs. J Psychopharmacol 12:115-121.
363. Schulz JB, Matthews R, Jenkins BG, Ferrante RJ, Siwek D, Henshaw DR, Cipollini PB, Mecocci P, Kowall NW, Rosen BR and Beal MF (1995) Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo. J Neurosci 15:8419-8429.
364. Schuman EM and Madison DV (1994) Nitric oxide and synaptic function. Annu Rev Neurosci 17:153-183.
365. Schwartz EA (1987) Depolarization without calcium can release γ-aminobutyric acid from a retinal neuron. Science (Wash DC) 238:350-355.
366. Schwartz EA and Tachibana M (1990) Electrophysiology of glutamate and sodium co-transport in a glial cell of the salamander retina. J Physiol (Lond) 426:43-80.
367. A receptor benzodiazepine site ligands. Neuropharmacology 36:823-830.
368. 2 adenosine receptors in the rat hippocampus. Neurosci Lett 138:41-44.
369. Segal M (1990) Serotonin attenuates a slow inhibitory postsynaptic potential in rat hippocampal neurons. Neuroscience 36:631-641.
370. Segovia G and Mora F (1998) Role of nitric oxide in modulating the release of dopamine, glutamate, and GABA in striatum of the freely moving rat. Brain Res Bull 45:275-279.
371. Seguela P, Watkins KC and Descarries L (1989) Ultrastructural relationships of serotonin axon terminals in the cerebral cortex of the adult rat. J Comp Neurol 289:129-142.
372. Seguela P, Watkins KC, Geffard M and Descarries L (1990) Noradrenaline axon terminals in adult rat neocortex: An immunocytochemical analysis in serial thin sections. Neuroscience 35:249-264.
373. Sershen H, Balla A, Lajtha A and Vizi ES (1997) Characterization of nicotinic receptors involved in the release of noradrenaline from the hippocampus. Neuroscience 77:121-130.
374. Sherrington C (1906) The Integrative Action of the Nervous System. Scribner Press, New York.
375. 2 receptor facilitates GABAergic neurotransmission in rat hippocampus. J Pharmacol Exp Ther 285:805-812.
376. Shim SS, Grant ER, Singh S, Gallagher MJ and Lynch DR (1999) Actions of butyrophenones and other antipsychotic agents at NMDA receptors: Relationship with clinical effects and structural considerations. Neurochem Int 34:167-175.
377. Shinomura T, Nakao S, Adachi T and Shingu K (1999) Clonidine inhibits and phorbol acetate activates glutamate release from rat spinal synaptoneurosomes. Anesth Analg 88:1401-1405.
378. A receptors. Neurochem Int 34:379-385.
379. Silverstone T (1985) Dopamine in manic depressive illness: A pharmacological synthesis. J Affect Disord 8:225-231.
380. Sitte HH, Huck S, Reither H, Boehm S, Singer EA and Pifl C (1998) Carrier-mediated release, transport rates, and charge transfer induced by amphetamine, tyramine, and dopamine in mammalian cells transfected with the human dopamine transporter. J Neurochem 71:1289-1297.
381. 1 dopamine receptor immunoreactivity in human and monkey cerebral cortex: Predominant and extra-synaptic localization in dendritic spines. Proc Natl Acad Sci USA 91:5720-5724.
382. A receptors in the cerebellum of rat, cat, and monkey using monoclonal antibodies. J Neurosci 9:2197-2209.
383. Sonders MS, Zhu SJ, Zahniser NR, Kavanaugh MP and Amara SG (1997) Multiple ionic conductances of the human dopamine transporter: The actions of dopamine and psychostimulants. J Neurosci 17:960-974.
384. Sora I, Wichems C, Takahashi N, Li XF, Zeng Z, Revay R, Leach KP, Murphy DL and Uhl GR (1998) Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice. Proc Natl Acad Sci USA 95:7699-7704.
385. 3H]acetylcholine from rat habenula slices. Neurochem Res 22:967-975.
386. 3H]noradrenaline from rat hypothalamic slices: Origin and modulation by α2-adrenoceptors. Neuroscience 82:511-520.
387. Sperlágh B and Vizi ES (1991) Effect of presynaptic P2 receptor stimulation on transmitter release. J Neurochem 56:1466-1470.
388. Sperlágh B and Vizi ES (1996) Neuronal synthesis, storage and release of ATP. Semin Neurosci 8:175-186.
389. 1-adenosine receptors in rat hippocampal slices. Int J Dev Neurosci 15:739-747.
390. 2-receptors after chronic desipramine treatment. Life Sci 27:1863-1867.
391. Stamford JA, Kruk ZL and Millar J (1986) In vivo voltammetric characterization of low affinity striatal dopamine uptake: Drug inhibition profile and relation to dopaminergic innervation density. Brain Res 373:85-91.
392. Starke K (1971) Influence of α-receptor stimulants on noradrenaline release. Naturwissenschaften 58:420.
393. Starke K (1977) Regulation of noradrenaline release by presynaptic receptor systems. Rev Physiol Biochem Pharmacol 77:1-124.
394. Starke K (1981) Presynaptic receptors. Annu Rev Pharmacol Toxicol 21:7-30.
395. Starke K, Göthert M and Kilbinger H (1989) Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol Rev 69:864-989.
396. Starke K, Taube HD and Borowski E (1977) Pre- and postsynaptic receptors in catecholaminergic transmission. Naunyn-Schmiedeberg's Arch Pharmacol 297: 43-44.
397. 3H]noradrenaline secretion in guinea-pig vas deferens: Possible role of extracellular sodium. Neuroscience 6:2759-2771.
398. Stjärne L (1989) Basic mechanisms and local modulation of nerve impulse-induced secretion of neurotransmitters from individual sympathetic nerve varicosities. Rev Physiol Biochem Pharmacol 112:1-137.
399. B receptors in presynaptic inhibition of 1a EPSPs in cat spinal motoneurons. J Physiol (Lond) 447:675-692.
400. 2-adrenoceptors during chronic antidepressants. Naunyn-Schmiedeberg's Arch Pharmacol 320:90-92.
401. Sun XP and Stanley EF (1996) An ATP-activated, ligand-gated ion channel on a cholinergic presynaptic nerve terminal. Proc Natl Acad Sci USA 93:1859-1863.
402. Svensson TH, Bunney BS and Aghajanian GK (1975) Inhibition of both noradrenergic and serotonergic neurons in brain by the α-adrenergic agonist clonidine. Brain Res 92:291.
403. Svoboda J and Sykova E (1991) Extracellular space volume changes in the rat spinal cord produced by nerve stimulation and peripheral injury. Brain Res 560:216-224.
404. Szabó C (1996) Physiological and pathophysiological roles of nitric oxide in the central nervous system. Brain Res Bull 41:131-141.
405. Szatkowski M, Barbour B and Attwell D (1990) Non-vesicular release of glutamate from glial cells by reversed electrogenic glutamate uptake. Nature (Lond) 348:443-445.
406. Taber MT and Fibiger HC (1994) Cortical regulation of acetylcholine release in rat striatum. Brain Res 639:354-356.
407. Takahashi T, Forsythe ID, Tsujimoto T, Barnes-Davies M and Onodera K (1996) Presynaptic calcium current modulation by a metabotropic glutamate receptor. Science (Wash DC) 274:594-597.
408. Tansey EM (1998) Not committing barbarisms: Sherrington and the synapse. Brain Res Bull 44:211-213.
409. Tapia R, Medina-Ceja L and Pena F (1999) On the relationship between extracellular glutamate, hyperexcitation and neurodegeneration, in vivo. Neurochem Int 34:23-32.
410. Tarnawa I and Vizi ES (1998) 2,3-Benzodiazepine AMPA antagonists. Restor Neurol Neurosci 13:41-57.
411. +-evoked release of endogenous glutamate from guinea pig hippocampal mossy fiber synaptosomes. Brain Res 551:303-307.
412. Thompson SM, Capogna M and Scanziani M (1993) Presynaptic inhibition in the hippocampus. Trends Neurosci 16:222-227.
413. Thureson-Klein Å (1983) Exocytosis from large and small dense cored vesicles in noradrenergic nerve terminals. Neuroscience 10:245-252.
414. Thureson-Klein Å (1984) The role of large and small noradrenergic vesicles in exocytosis, in Catecholamines: Basic and Peripheral Mechanisms (Usdin E and Liss AR) pp 79-87, New York.
415. Thureson-Klein Å and Stjärne L (1981) Dense cored vesicles in actively secreting noradrenergic neurons, in Chemical Neurotransmission 75 Years (Stjärne L, Hedqvuist P, Lagercrantz H and Wennmalm A eds) pp 139-164, Academic Press, London.
416. Toner CC and Stamford JA (1999) Effects of metabolic alterations on dopamine release in an in vitro model of neostriatal ischaemia. Brain Res Bull 48:395-399.
417. Tong G and Jahr CE (1994) Block of glutamate transporters potentiates postsynaptic excitation. Neuron 13:1195-1203.
418. Toth E, Vizi ES and Lajtha A (1993) Effect of nicotine on levels of extracellular amino acids in regions of the rat brain in vivo. Neuropharmacology 32:827-832.
419. Törk I (1990) Anatomy of the serotonergic system. Ann NY Acad Sci 600:9-35.
420. Trendelenburg U (1991) The TIPS lecture: Functional aspects of the neuronal uptake of noradrenaline. Trends Pharmacol Sci 32:334-337.
421. 2A in the rabbit. Naunyn-Schmiedeberg's Arch Pharmacol 348:35-45.
422. 2-autoreceptors. Naunyn-Schmiedeberg's Arch Pharmacol 349:25-33.
423. + channel block prevents the ischemia-induced release of norepinephrine from spinal cord slices. Eur J Pharmacol 346:145-150.
424. Umbriaco D, Garcia S, Beaulieu C and Descarries L (1995) Relational features of acetylcholine, noradrenaline, serotonin and GABA axon terminals in the stratum radiatum of adult rat hippocampus (CA1). Hippocampus 5:605-620.
425. 3H]-noradrenaline from rat spinal cord. Brain Res Bull 42:129-132.
426. Van Horne C, Hoffer BJ, Stromberg I and Gerhardt GA (1992) Clearance and diffusion of locally applied dopamine in normal and 6-hydroxydopamine lesioned rat striatum. J Pharmacol Exp Ther 263:1285-1292.
427. Van der Kloot W and Molgo J (1994) Quantal acetylcholine release at the vertebrate neuromuscular junction. Physiol Rev 74:899-991.
428. - conductance in cultured rat hippocampal neurons. J Physiol (Lond) 479:53-63.
429. 2A-adrenergic receptors in the visual cortex of neonatal and adult rats. J Comp Neurol 365:79-95.
430. Vizi ES (1968) The inhibitory action of noradrenaline and adrenaline on release of acetylcholine from guinea-pig ileum longitudinal strips. Naunyn-Schmiedeberg's Arch Pharmac Exp Pathol 259:199-200.
431. 2+) activated ATPase, of acetylcholine release in cortical slices from rat brain. J Physiol (Lond) 226:95-117.
432. Vizi ES (1974) Interaction between adrenergic and cholinergic systems presynaptic inhibitory effect of noradrenaline on acetylcholine release. J Neural Transm Suppl 11:61-78.
433. + activated adenosinetriphosphatase as a trigger in transmitter release. Neuroscience 3:367-384.
434. Vizi ES (1979) Presynaptic modulation of neurochemical transmission. Progr Neurobiol 12:181-290.
435. Vizi ES (1980a) Nonsynaptic modulation of transmitter release: Pharmacological implication. Trends Pharmacol Sci 1:172-175.
436. Vizi ES (1980b) Modulation of cortical release of acetylcholine by noradrenaline released from nerves arising from the rat locus coeruleus. Neuroscience 5:2139-2144.
437. Vizi ES (1984a) Nonsynaptic Interactions between Neurons: Modulation of Neurochemical Transmission. John Wiley and Sons, Chichester/New York.
438. Vizi ES (1984b) Physiological role of cytoplasmic and non-synaptic release of transmitter. Neurochem Int 6:435-440.
439. Vizi ES (1990) Synaptic and nonsynaptic cross talk between neurons. Ann NY Acad Sci 604:344-352.
440. Vizi ES (1991) Nonsynaptic inhibitory signal transmission between axon terminals: Physiological and pharmacological evidence, in Volume Transmission in the Brain: Novel Mechanisms for Neural Transmission (Fuxe K and Agnati LF eds) pp 89-96, Raven Press, New York.
441. Vizi ES (1998) Different temperature dependence of carrier-mediated (cytoplasmic) and stimulus-evoked (exocytotic) release of transmitter: A simple method to separate the two types of release. Neurochem Int 33:359-366.
442. Vizi ES and Kiss JP (1998) Neurochemistry and pharmacology of the major hippocampal transmitter systems: Synaptic and nonsynaptic interactions. Hippocampus 8:566-607.
443. Vizi ES, Kiss JP and Elenkov IJ (1991) Presynaptic modulation of cholinergic and noradrenergic neurotransmission: Interaction between them. News Phys Sci 6:119-123.
444. Vizi ES and Knoll J (1971) The effects of sympathetic nerve stimulation and guanethidine on parasympathetic neuroeffector transmission, the inhibition of acetylcholine release. J Pharm Pharmacol 23:918-925.
445. Vizi ES and Knoll J (1976) The inhibitory effect of adenosine and related nucleotides on the release of acetylcholine. Neuroscience 1:391-398.
446. Vizi ES and Lábos E (1991) Nonsynaptic interactions at presynaptic level. Progr Neurobiol 37:145-163.
447. Vizi ES and Lendvai B (1997) Side effects of nondepolarizing muscle relaxants: Relationship to their antinicotinic and antimuscarinic actions. Pharmacol Ther 73:75-89.
448. Vizi ES and Lendvai B (1999) Modulatory role of presynaptic nicotinic receptors in synaptic and nonsynaptic chemical communication in the central nervous system. Brain Res Rev, in press.
449. Vizi ES, Mike A and Tarnawa I (1996) 2,3-Benzodiazepines (GYKI 52466 and analogs): Negative allosteric modulators of AMPA receptors. CNS Drug Rev 2:91-126.
450. Vizi ES, Mike A and Tarnawa I (1997) The functional study of kainate receptors: Hopes and doubts. Trends Neurosci 20:396-397.
451. Vizi ES, Orsó E, Osipenko ON, Haskó G and Elenkov I (1995a) Neurochemical, electrophysiological and immunocytochemical evidence for a noradrenergic link between the sympathetic nervous system and thymocytes. Neuroscience 68:1263-1276.
452. Vizi ES, Sershen H, Balla A, Mike A, Windisch K, Juranyi Z and Lajtha A (1995b) Neurochemical evidence of heterogeneity of presynaptic and somatodendritic nicotinic acetylcholine receptors. Ann NY Acad Sci 757:84-99.
453. Vizi ES, Somogyi GT, Hársing LG Jr and Zimanyi I (1985) External Ca-independent release of norepinephrine by sympathomimetics and its role in negative feedback modulation. Proc Natl Acad Sci USA 82:8775-8780.
454. Vizi ES and Sperlágh B (1999) Separation of carrier-mediated and vesicular release of GABA from rat brain slices. Neurochem Int 34:407-413.
455. 3H]noradrenaline release in rabbit brain cortex slices by direct action at presynaptic adenosine A1-receptors. Naunyn-Schmiedeberg's Arch Pharmacol 346:187-196.
456. Von Kügelgen I, Späth L and Starke K (1994) Evidence for P2-purinoceptor-mediated inhibition of noradrenaline release in rat brain cortex. Br J Pharmacol 113:815-822.
457. Wall SJ, Wolfe BB and Kromer LF (1994) Cholinergic deafferentation of dorsal hippocampus by fimbria-fornix lesioning differentially regulates subtypes (m1-m5) of muscarinic receptors. J Neurochem 62:1345-1351.
458. West AR and Galloway MP (1999) Nitric oxide and potassium chloride-facilitated striatal dopamine efflux in vivo: Role of calcium-dependent release mechanisms. Neurochem Int 33:493-501.
459. West DP and Fillenz M (1980) Storage and release of noradrenaline in hypothalamic synaptosomes. J Neurochem 35:1323-1328.
460. Westfall TC (1977) Local regulation of adrenergic neurotransmission. Phys Rev 57:659-728.
461. Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT and DeLong M (1982) Alzheimer's disease and senile dementia: Loss of neurons in the basal forebrain. Science (Wash DC) 215:1237-1239.
462. Whiting PJ (1999) The GABAA receptor gene family: New targets for therapeutic intervention. Neurochem Int 34:387-390.
463. Wightman RM, Amatore C, Engstrom RC, Hale PD, Kristensen EW, Kuhr WG and Hale LJ (1988) Real time characterization of dopamine overflow and uptake in the rat striatum. Neuroscience 25:513-523.
464. Wilkie GI, Hutson P, Sullivan JP and Wonnacott S (1996) Pharmacological characterization of a nicotinic autoreceptor in rat hippocampal synaptosomes. Neurochem Res 21:1141-1148.
465. 2A messenger RNA expression. Neuroscience 76:241-260.
466. 3H]rauwolscine binding. Neuroscience 76:261-272.
467. Wonnacott S (1997) Presynaptic nicotinic ACh receptors. Trends Neurosci 20:92-98.
468. Wonnacott S, Irons J, Rapier C, Thorne B and Lunt GG (1989) Presynaptic modulation of transmitter release by nicotinic receptors. Prog Brain Res 79:157-163.
469. Wonnacott S, Wilkie G, Soliakov L and Whiteaker P (1995) Presynaptic nicotinic autoreceptors and heteroreceptors in the CNS, in Effects of Nicotine on Biological Systems: Advances in Pharmacological Sciences, Vol. II. (Clarke P, Quik M, Adlkofer F and Thurau K eds) pp 87-94, Birkhauser Verlag Press, Basel.
470. Wu L-G and Saggau P (1997) Presynaptic inhibition of elicited neurotransmitter release. Trends Neurol Sci 20:204-212.
471. Yamazaki T, Akiyama T, Kitagawa H, Takauchi Y and Kawada T (1996) Elevation of either axoplasmic norepinephrine or sodium level induced release of norepinephrine from cardiac sympathetic nerve terminals. Brain Res 737:343-346.
472. 2 dopamine receptors in the basal ganglia of the rat: Light and electron microscopy. Neuroscience 65:709-730.
473. Zahniser NR, Gerhardt GA, Hoffman AF and Lupica CR (1998) Voltage-dependency of the dopamine transporter in rat brain. Adv Pharmacol 42:195-198.
474. +-evoked dopamine release from rat olfactory tubercle and striatal slices. Br J Pharmacol 113:968-972.
475. Zevin S, Gourlay SG and Benowitz NL (1998) Clinical pharmacology of nicotine. Clin Dermatol 16:557-564.
476. Zhang L, Coffey LL and Reith EA (1997) Regulation of functional activity of the human dopamine transporter by protein kinase C. Biochem Pharmacol 53:677-688.
477. Zhang YX, Yamashita H, Oshita T, Sawamoto N and Nakamura S (1996) ATP induces release of newly synthesized dopamine in rat striatum. Neuroscience 28:395-400.
478. Zhu PC, Thureson-Klein Å and Klein RL (1986) Exocytosis from large dense cored vesicles outside the active synaptic zones of terminals within the trigeminal subnucleus caudalis: A possible mechanism for neuropeptide release. Neuroscience 19:43-54.
479. Zhu S-J, Kavanaugh MP, Sonders MS, Amara SG and Zahniser NR (1997) Activation of protein kinase C inhibits uptake, currents and binding associated with the human dopamine transporter expressed in Xenopus oocytes. J Pharmacol Exp Ther 282:1358-1365.
480. Zoli M and Agnati LF (1996) Wiring and volume transmission in the central nervous system: The concept of closed and open synapses. Prog Neurobiol 49:363-380.
481. Zoli M, Jansson A, Syková E, Agnati LF and Fuxe K (1999) Volume transmission in the CNS and its relevance for neuropsychopharmacology. Trends Pharmacol Sci 20:142-150.